ACUTE-RENAL-FAILURE IN PATIENTS FOLLOWING BONE-MARROW TRANSPLANTATION - PREVALENCE, RISK-FACTORS AND OUTCOME

被引:93
作者
GRUSS, E [1 ]
BERNIS, C [1 ]
TOMAS, JF [1 ]
GARCIACANTON, C [1 ]
FIGUERA, A [1 ]
MOTELLON, JL [1 ]
PARAISO, V [1 ]
TRAVER, JA [1 ]
FERNANDEZRANADA, JM [1 ]
机构
[1] AUTONOMOUS UNIV MADRID,PRINCESSA HOSP,DEPT HEMATOL,E-28031 MADRID,SPAIN
关键词
ACUTE RENAL FAILURE; BONE MARROW TRANSPLANTATION; VENOOCCLUSIVE DISEASE; LIVER;
D O I
10.1159/000168889
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To assess the prevalence, risk factors, clinical causes and outcome of acute renal failure (ARF) following bone marrow transplantation (BMT), a retrospective analysis of 275 patients was undertaken. ARF was diagnosed in 72 patients (26%) and occurred in 81.9% within the first month. The three main clinical causes were multifactorial (36%), nephrotoxic (29%), and veno-occlusive disease of the liver (VOD) 15%. The prevalence was higher in allogeneic BMT (36%) than in autologous BMT (6.5%). Risk factors related to the development of ARF were preexisting VOD and age older than 25 years. Logistic regression in allogeneic BMT confirmed this association (VOD, odds ratio 3.8; age ofer than 25, odds ratio 1.9). Underlying disease, graft-versus-host disease, sepsis, conditioning therapy, and sex were not associated with ARF. Seventeen cases of ARF required hemodialysis (24%) mainly in association with VOD (70.5%). The overall mortality from ARF was 45.8%, the dialyzed group having the highest mortality (88%). Survival in the ARF group was continuously worse up to 3 months and the actuarial survival at 10 years was 29.7 versus 53.2%. We conclude that ARF is a common complication mainly in allogeneic BMT and carries a grave prognosis. VOD and age were risk factors for ARF.
引用
收藏
页码:473 / 479
页数:7
相关论文
共 31 条
  • [1] SYSTEMIC CAPILLARY LEAK SYNDROME AND MONOCLONAL IGG GAMMOPATHY - STUDIES IN A 6TH PATIENT AND A REVIEW OF LITERATURE
    ATKINSON, JP
    WALDMANN, TA
    STEIN, SF
    GELFAND, JA
    MACDONALD, WJ
    HECK, LW
    COHEN, EL
    KAPLAN, AP
    FRANK, MM
    [J]. MEDICINE, 1977, 56 (03) : 225 - 239
  • [2] BAGIN TP, 1990, BONE MARROW TRANSPL, V5, P439
  • [3] BIANCO JA, 1991, BLOOD, V78, P1205
  • [4] BORTIN MM, 1992, BONE MARROW TRANSPL, V10, P113
  • [5] TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-ALPHA IN CHRONIC LIVER-DISEASE - EFFECTS OF INTERFERON ALFA THERAPY
    CASTILLA, A
    PRIETO, J
    FAUSTO, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 933 - 940
  • [6] CHAMPLIN R, 1987, SEMIN HEMATOL, V24, P55
  • [7] CHAPMAN JR, 1985, LANCET, V1, P128
  • [8] NEPHROTOXICITY ASSOCIATED WITH COMBINED GENTAMICIN-AMPHOTERICIN-B THERAPY
    CHURCHILL, DN
    SEELY, J
    [J]. NEPHRON, 1977, 19 (03): : 176 - 181
  • [9] THE HEMOLYTIC UREMIC SYNDROME AND BONE-MARROW TRANSPLANTATION
    CRAIG, JIO
    SHEEHAN, T
    BELL, K
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6603): : 887 - 887
  • [10] DERAY G, 1993, 39TH C EDTA GLASG